164 related articles for article (PubMed ID: 15014030)
1. [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
Zhang H; Yoshikawa K; Tamura K; Tomemori T; Sagou K; Tian M; Kandatsu S; Kamada T; Tsuji H; Suhara T; Suzuki K; Tanada S; Tsujii H
Clin Cancer Res; 2004 Mar; 10(5):1764-72. PubMed ID: 15014030
[TBL] [Abstract][Full Text] [Related]
2. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
[TBL] [Abstract][Full Text] [Related]
3. 11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer.
Koizumi M; Saga T; Yoshikawa K; Suzuki K; Yamada S; Hasebe M; Ohashi S; Abd-Elrazek S; Ishikawa H; Sagou K; Tamura K; Hara R; Kato H; Yasuda S; Yanagi T; Tsujii H
Mol Imaging Biol; 2008; 10(6):374-80. PubMed ID: 18679757
[TBL] [Abstract][Full Text] [Related]
4. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
[TBL] [Abstract][Full Text] [Related]
5. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Bastiaannet E; Groen H; Jager PL; Cobben DC; van der Graaf WT; Vaalburg W; Hoekstra HJ
Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
[TBL] [Abstract][Full Text] [Related]
6. A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.
Hasebe M; Yoshikawa K; Ohashi S; Toubaru S; Kawaguchi K; Sato J; Mizoe J; Tsujii H
Mol Imaging Biol; 2010 Oct; 12(5):554-62. PubMed ID: 20369300
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
Kamada T; Tsujii H; Tsuji H; Yanagi T; Mizoe JE; Miyamoto T; Kato H; Yamada S; Morita S; Yoshikawa K; Kandatsu S; Tateishi A;
J Clin Oncol; 2002 Nov; 20(22):4466-71. PubMed ID: 12431970
[TBL] [Abstract][Full Text] [Related]
8. Carbon-11-methionine positron emission tomography imaging of chordoma.
Zhang H; Yoshikawa K; Tamura K; Sagou K; Tian M; Suhara T; Kandatsu S; Suzuki K; Tanada S; Tsujii H
Skeletal Radiol; 2004 Sep; 33(9):524-30. PubMed ID: 15483754
[TBL] [Abstract][Full Text] [Related]
9. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
Eary JF; O'Sullivan F; Powitan Y; Chandhury KR; Vernon C; Bruckner JD; Conrad EU
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1149-54. PubMed ID: 12192559
[TBL] [Abstract][Full Text] [Related]
10. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of
Hasebe M; Yoshikawa K; Nishii R; Kawaguchi K; Kamada T; Hamada Y
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1220-1228. PubMed ID: 28535963
[TBL] [Abstract][Full Text] [Related]
12. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
[TBL] [Abstract][Full Text] [Related]
13. A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.
Kohama I; Yanagawa T; Okamoto M; Ohno T; Chikuda H
Asia Pac J Clin Oncol; 2022 Aug; 18(4):434-440. PubMed ID: 34811886
[TBL] [Abstract][Full Text] [Related]
14. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas.
Yuce Sari S; Cengiz M; Dauletkazin A; Yazici G; Gultekin M; Hurmuz P; Yildiz F; Zorlu F; Gurkaynak M; Akyol F; Ozyigit G
Cancer Radiother; 2019 Dec; 23(8):853-859. PubMed ID: 31640927
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
Li YJ; Dai YL; Cheng YS; Zhang WB; Tu CQ
Eur J Surg Oncol; 2016 Aug; 42(8):1103-14. PubMed ID: 27189833
[TBL] [Abstract][Full Text] [Related]
17. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
Schuetze SM; Rubin BP; Vernon C; Hawkins DS; Bruckner JD; Conrad EU; Eary JF
Cancer; 2005 Jan; 103(2):339-48. PubMed ID: 15578712
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. [S-methyl-
Narushima K; Nishii R; Okazumi S; Shimada H; Akutsu Y; Maeda T; Yasuda S; Yamada S; Shuto K; Tamura K; Yamazaki K; Shinoto M; Ishikawa H; Mori M; Matsubara H
Sci Rep; 2022 Aug; 12(1):13694. PubMed ID: 35953702
[TBL] [Abstract][Full Text] [Related]
20. Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma.
Takenaka S; Araki N; Outani H; Hamada KI; Yoshikawa H; Kamada T; Imai R
Cancer; 2020 Sep; 126(18):4188-4196. PubMed ID: 32658315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
